Spartalis, E., Athanasiou, A., Spartalis, M., Moris, D., Papalampros, A., & Nikiteas, N. (2017). Platelet-rich plasma and peripheral nerve regeneration: a potential contraindication to its use after tumor excision. Expert Opinion on Biological Therapy, 17(8), 1045–1046. https://doi.org/10.1080/14712598.2017.1349480

Spartalis, Eleftherios, Antonios Athanasiou, Michael Spartalis, Demetrios Moris, Alexandros Papalampros, and Nikolaos Nikiteas. “Platelet-rich plasma and peripheral nerve regeneration: a potential contraindication to its use after tumor excision.” Expert Opinion on Biological Therapy 17, no. 8 (August 2017): 1045–46. https://doi.org/10.1080/14712598.2017.1349480.

Spartalis E, Athanasiou A, Spartalis M, Moris D, Papalampros A, Nikiteas N. Platelet-rich plasma and peripheral nerve regeneration: a potential contraindication to its use after tumor excision. Expert opinion on biological therapy. 2017 Aug;17(8):1045–6.

Spartalis, Eleftherios, et al. “Platelet-rich plasma and peripheral nerve regeneration: a potential contraindication to its use after tumor excision.” Expert Opinion on Biological Therapy, vol. 17, no. 8, Aug. 2017, pp. 1045–46. Epmc, doi:10.1080/14712598.2017.1349480.

Spartalis E, Athanasiou A, Spartalis M, Moris D, Papalampros A, Nikiteas N. Platelet-rich plasma and peripheral nerve regeneration: a potential contraindication to its use after tumor excision. Expert opinion on biological therapy. 2017 Aug;17(8):1045–1046.